Shanghai blood products firm’s stock dives 63.2b yuan

Shanghai RAAS said that “fluctuations in the capital market” were the main reason for the firm’s net … Shanghai RAAS acknowledged that controlling stakeholders’ “stock pledging loans have defaulted …
( read original story …)


Related Post